SARMA, A.; KATAKI, A.; RAI, A.; HAZARIKA, M.; ROY, P.; KALITA, M.; DEKA, M.; CHATTOPADHYAY, I. Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. Asian Pacific Journal of Cancer Care, v. 8, n. 1, p. 35-42, 17 fev. 2023.